Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C5H11NO2S |
Molecular Weight | 149.211 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCSC[C@H](N)C(O)=O
InChI
InChIKey=ULXKXLZEOGLCRJ-BYPYZUCNSA-N
InChI=1S/C5H11NO2S/c1-2-9-3-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/27548215Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27548215 | https://www.ncbi.nlm.nih.gov/pubmed/15234988 | https://www.ncbi.nlm.nih.gov/pubmed/17995665 | https://www.ncbi.nlm.nih.gov/pubmed/26372842
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27548215
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27548215 | https://www.ncbi.nlm.nih.gov/pubmed/15234988 | https://www.ncbi.nlm.nih.gov/pubmed/17995665 | https://www.ncbi.nlm.nih.gov/pubmed/26372842
S-ETHYLCYSTEINE is hydrophilic cysteine-containing compound naturally synthesized in many Allium plant foods such as garlic and onion. Dietary intake of S-Ethyl-L-cysteine displayed anti-oxidative and anti-inflammatory protection against ethanol-induced liver injury in mice. S-Ethyl-L-cysteine ameliorated H2O2-induced apoptotic, oxidative and inflammatory injury in human BEAS-2B cells (bronchial cells) through preserving Bcl-2 expression, decreasing ROS formation and limiting protein expression of NAPDH oxidase, NF-kB, and MAPK. S-Ethyl-L-cysteine is used as the chiral reagent.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0006954 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27548215 |
|||
Target ID: WP408 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27548215 |
|||
Target ID: WP1018 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27548215 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27548215
As drinking water supplement: 0.5 g or 1 g mixed with 99.5 or 99 mL distilled water for 3 days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26372842
Thus, 6 h incubation was applied for this study. Stock solution of SEC (S-ETHYLCYSTEINE) was prepared, and used for further dilution by bronchial epithelial growth medium (BEGM). BEAS- 2B cells were routinely cultured in BEGM, treated by 2.5 mM l-glutamine, 10% fetal calf serum, 100 units/mL streptomycin, and 100 units/mL penicillin (pH 7.4) under 95% air and 5% CO2 at 37 °C. Culture medium was changed every 72 h, and cells were subcultured every 7 d. Phosphate buffer saline (PBS, pH 7.2) was added to adjust cell number to 105/mL for experiments and analyses. After aspiration, cells were incubated with S-ETHYLCYSTEINE at 4, 8, or 16 μmol/L at 37 °C for 6-h, which caused 96.4 ± 1.2% incorporation of target compound into BEAS-2B cells. Cells were further treated by 100 μMH2O2 at 37 °C for 4 h
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C026826
Created by
admin on Sat Dec 16 05:03:42 GMT 2023 , Edited by admin on Sat Dec 16 05:03:42 GMT 2023
|
PRIMARY | |||
|
22196-52-7
Created by
admin on Sat Dec 16 05:03:42 GMT 2023 , Edited by admin on Sat Dec 16 05:03:42 GMT 2023
|
PRIMARY | |||
|
24513
Created by
admin on Sat Dec 16 05:03:42 GMT 2023 , Edited by admin on Sat Dec 16 05:03:42 GMT 2023
|
PRIMARY | RxNorm | ||
|
92185
Created by
admin on Sat Dec 16 05:03:42 GMT 2023 , Edited by admin on Sat Dec 16 05:03:42 GMT 2023
|
PRIMARY | |||
|
156209
Created by
admin on Sat Dec 16 05:03:42 GMT 2023 , Edited by admin on Sat Dec 16 05:03:42 GMT 2023
|
PRIMARY | |||
|
156145
Created by
admin on Sat Dec 16 05:03:42 GMT 2023 , Edited by admin on Sat Dec 16 05:03:42 GMT 2023
|
PRIMARY | |||
|
SUB180396
Created by
admin on Sat Dec 16 05:03:42 GMT 2023 , Edited by admin on Sat Dec 16 05:03:42 GMT 2023
|
PRIMARY | |||
|
B46YS921BY
Created by
admin on Sat Dec 16 05:03:42 GMT 2023 , Edited by admin on Sat Dec 16 05:03:42 GMT 2023
|
PRIMARY |
ACTIVE MOIETY